Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★ View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-07

AUTHORS

Victor A. Levin, Surasak Phuphanich, W.K. Alfred Yung, Peter A. Forsyth, Rolando Del Maestro, James R. Perry, Gregory N. Fuller, Mark Baillet

ABSTRACT

PURPOSE: Because raised matrix metalloprotease (MMP) levels are associated with glioma invasion and angiogenesis, we tested the efficacy of marimastat (MT) an orally active drug that can reduce MMP levels, in patients with gliomas. PATIENTS AND METHODS: A total of 162 patients with intracranial glioblastoma multiforme or gliosarcomas who had undergone surgery and radiotherapy participated in this multicenter, double-blind, placebo-controlled, parallel group study conducted at 20 institutions. Seventy-nine patients (57 male, 22 female, median age 58 years) were randomized to receive placebo (PB), and 83 patients (51 male, 32 female, median age 57 years) were randomized to receive MT, 10 mg orally twice daily, until tumor progression. RESULTS: This intention-to-treat efficacy analysis showed no statistically significant difference between MT and PB groups with respect to survival (P = 0.38, log rank test). The median survival time from protocol initiation was 37.9 weeks for the PB group and 42.9 weeks for the MT group, with a hazard ratio of 1.16 (95% CI 0.83 to 1.60). There were no statistically significant differences in quality of life between the PB and MT groups, as assessed by the FACT-BR questionnaire. Musculoskeletal toxicities led to dose modification or withdrawal in 20% of MT-treated and 1.2% of PB-treated patients. CONCLUSION: MT does not improve survival in patients with glioblastoma or gliosarcoma following surgery and radiotherapy. Therefore, single-agent MT appears unwarranted; however, MT in combination with cytotoxic chemotherapy may be warranted, as suggested by observations in our study and other studies. More... »

PAGES

295-302

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-005-9098-5

DOI

http://dx.doi.org/10.1007/s11060-005-9098-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049009949

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16636750


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gliosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxamic Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Matrix Metalloproteinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Matrix Metalloproteinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Musculoskeletal Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA", 
            "Neuro-Oncology Unit 431, UT M. D. Anderson Cancer Center, P.O. Box 301402, 77230-1402, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levin", 
        "givenName": "Victor A.", 
        "id": "sg:person.0750205222.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750205222.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Emory University", 
          "id": "https://www.grid.ac/institutes/grid.189967.8", 
          "name": [
            "Department of Hematology-Oncology, Winship Cancer Institute, Emory University, 30322, Atlanta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Phuphanich", 
        "givenName": "Surasak", 
        "id": "sg:person.01346246457.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346246457.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alfred Yung", 
        "givenName": "W.K.", 
        "id": "sg:person.016341673457.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016341673457.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Alberta Health Services", 
          "id": "https://www.grid.ac/institutes/grid.413574.0", 
          "name": [
            "Tom Baker Cancer Center, Calgary, Alberta, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Forsyth", 
        "givenName": "Peter A.", 
        "id": "sg:person.0723474462.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723474462.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Department of Neurosciences, Division of Neurosurgery, University of Western Ontario, London, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Maestro", 
        "givenName": "Rolando", 
        "id": "sg:person.0636405632.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636405632.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sunnybrook Health Science Centre", 
          "id": "https://www.grid.ac/institutes/grid.413104.3", 
          "name": [
            "Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perry", 
        "givenName": "James R.", 
        "id": "sg:person.0751336044.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751336044.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fuller", 
        "givenName": "Gregory N.", 
        "id": "sg:person.013732343337.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013732343337.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "The Marimastat Glioblastoma Study Group* and British Biotech, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baillet", 
        "givenName": "Mark", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1074/jbc.m006871200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000021777"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342262", 
          "https://doi.org/10.1038/nrc884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342262", 
          "https://doi.org/10.1038/nrc884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19950301)75:5<1151::aid-cncr2820750515>3.0.co;2-q", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006358852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007980454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00157684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008182837", 
          "https://doi.org/10.1007/bf00157684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00157684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008182837", 
          "https://doi.org/10.1007/bf00157684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015454211", 
          "https://doi.org/10.1038/nrc1121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015454211", 
          "https://doi.org/10.1038/nrc1121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00157681", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026844027", 
          "https://doi.org/10.1007/bf00157681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00157681", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026844027", 
          "https://doi.org/10.1007/bf00157681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.274.33.23349", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039215449"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.272.46.28823", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039952409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.274.41.29568", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044358587"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045826895", 
          "https://doi.org/10.1054/bjoc.2000.1316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt1974155443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048844100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1204097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050913107", 
          "https://doi.org/10.1038/sj.onc.1204097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1204097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050913107", 
          "https://doi.org/10.1038/sj.onc.1204097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0065-2571(94)00022-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052218121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1067100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062445674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.5.1383", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1977.47.3.0329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071091255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1977.47.3.0329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071091255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1977.47.3.0329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071091255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1996.84.1.0029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071097867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1996.84.1.0029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071097867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1996.84.1.0029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071097867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.7.1481", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074611338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074718587", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075265107", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.7.1277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082676509", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.annonc.a059091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082936497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083269733", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-07", 
    "datePublishedReg": "2006-07-01", 
    "description": "PURPOSE: Because raised matrix metalloprotease (MMP) levels are associated with glioma invasion and angiogenesis, we tested the efficacy of marimastat (MT) an orally active drug that can reduce MMP levels, in patients with gliomas.\nPATIENTS AND METHODS: A total of 162 patients with intracranial glioblastoma multiforme or gliosarcomas who had undergone surgery and radiotherapy participated in this multicenter, double-blind, placebo-controlled, parallel group study conducted at 20 institutions. Seventy-nine patients (57 male, 22 female, median age 58 years) were randomized to receive placebo (PB), and 83 patients (51 male, 32 female, median age 57 years) were randomized to receive MT, 10 mg orally twice daily, until tumor progression.\nRESULTS: This intention-to-treat efficacy analysis showed no statistically significant difference between MT and PB groups with respect to survival (P = 0.38, log rank test). The median survival time from protocol initiation was 37.9 weeks for the PB group and 42.9 weeks for the MT group, with a hazard ratio of 1.16 (95% CI 0.83 to 1.60). There were no statistically significant differences in quality of life between the PB and MT groups, as assessed by the FACT-BR questionnaire. Musculoskeletal toxicities led to dose modification or withdrawal in 20% of MT-treated and 1.2% of PB-treated patients.\nCONCLUSION: MT does not improve survival in patients with glioblastoma or gliosarcoma following surgery and radiotherapy. Therefore, single-agent MT appears unwarranted; however, MT in combination with cytotoxic chemotherapy may be warranted, as suggested by observations in our study and other studies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-005-9098-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "78"
      }
    ], 
    "name": "Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation\u2605", 
    "pagination": "295-302", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e979d36a22b7f32ec25a18a3d21d3da8291e74bcd87f06b2630c209a42bf00cd"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16636750"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-005-9098-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049009949"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-005-9098-5", 
      "https://app.dimensions.ai/details/publication/pub.1049009949"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000534.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-005-9098-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-005-9098-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-005-9098-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-005-9098-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-005-9098-5'


 

This table displays all metadata directly associated to this object as RDF triples.

286 TRIPLES      21 PREDICATES      73 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-005-9098-5 schema:about N16f8434d96aa4485aa6cf0688ed25622
2 N1f15e54bb85b4211be2de032aa04933d
3 N2063ac7adbb14f5aa1056fde400c5b86
4 N250d3118ab814c8f81e8d05dd5adf6b6
5 N2ab583f22a2e485fa136000eaaadd2ad
6 N52a0a134f6c04097b08ac83367fc8ee8
7 N53a89e8888b1451c9adb8d63d029677c
8 N5c0469a79e4b43cf8d12b512d4cdd339
9 N5fba498171c64bd9999ec95905cdd531
10 N6f0524d307d54a01b6d7beaa37c1e54d
11 N7e2a5327350e4082a366d322bfd38360
12 N909e77b257dd44d2a5e105633da1a49e
13 N975e7d0be2f542858e3187737baeacf1
14 Na644075a55334a898b2e92af53d37626
15 Nb2d738adbf9042ccb511b81ce48ce777
16 Nbcbe7ccc85d74cfa8cbde7b32c555826
17 Ncfef4207b1394278bcda848e3fb48bb3
18 Ne9752604f40b4c7a86671a06255aac6e
19 Nfc5c687d77514803983e90a174a00c29
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author Nf19eb3c110ec499d98afdb1e565a126f
23 schema:citation sg:pub.10.1007/bf00157681
24 sg:pub.10.1007/bf00157684
25 sg:pub.10.1038/nrc1121
26 sg:pub.10.1038/nrc884
27 sg:pub.10.1038/sj.onc.1204097
28 sg:pub.10.1054/bjoc.2000.1316
29 https://app.dimensions.ai/details/publication/pub.1074718587
30 https://app.dimensions.ai/details/publication/pub.1075265107
31 https://app.dimensions.ai/details/publication/pub.1082676509
32 https://app.dimensions.ai/details/publication/pub.1083269733
33 https://doi.org/10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2
34 https://doi.org/10.1002/1097-0142(19950301)75:5<1151::aid-cncr2820750515>3.0.co;2-q
35 https://doi.org/10.1002/cpt1974155443
36 https://doi.org/10.1016/0065-2571(94)00022-u
37 https://doi.org/10.1074/jbc.272.46.28823
38 https://doi.org/10.1074/jbc.274.33.23349
39 https://doi.org/10.1074/jbc.274.41.29568
40 https://doi.org/10.1074/jbc.m006871200
41 https://doi.org/10.1093/oxfordjournals.annonc.a059091
42 https://doi.org/10.1126/science.1067100
43 https://doi.org/10.1200/jco.1990.8.7.1277
44 https://doi.org/10.1200/jco.20.5.1383
45 https://doi.org/10.1200/jco.2000.18.7.1481
46 https://doi.org/10.3171/jns.1977.47.3.0329
47 https://doi.org/10.3171/jns.1996.84.1.0029
48 schema:datePublished 2006-07
49 schema:datePublishedReg 2006-07-01
50 schema:description PURPOSE: Because raised matrix metalloprotease (MMP) levels are associated with glioma invasion and angiogenesis, we tested the efficacy of marimastat (MT) an orally active drug that can reduce MMP levels, in patients with gliomas. PATIENTS AND METHODS: A total of 162 patients with intracranial glioblastoma multiforme or gliosarcomas who had undergone surgery and radiotherapy participated in this multicenter, double-blind, placebo-controlled, parallel group study conducted at 20 institutions. Seventy-nine patients (57 male, 22 female, median age 58 years) were randomized to receive placebo (PB), and 83 patients (51 male, 32 female, median age 57 years) were randomized to receive MT, 10 mg orally twice daily, until tumor progression. RESULTS: This intention-to-treat efficacy analysis showed no statistically significant difference between MT and PB groups with respect to survival (P = 0.38, log rank test). The median survival time from protocol initiation was 37.9 weeks for the PB group and 42.9 weeks for the MT group, with a hazard ratio of 1.16 (95% CI 0.83 to 1.60). There were no statistically significant differences in quality of life between the PB and MT groups, as assessed by the FACT-BR questionnaire. Musculoskeletal toxicities led to dose modification or withdrawal in 20% of MT-treated and 1.2% of PB-treated patients. CONCLUSION: MT does not improve survival in patients with glioblastoma or gliosarcoma following surgery and radiotherapy. Therefore, single-agent MT appears unwarranted; however, MT in combination with cytotoxic chemotherapy may be warranted, as suggested by observations in our study and other studies.
51 schema:genre research_article
52 schema:inLanguage en
53 schema:isAccessibleForFree false
54 schema:isPartOf N290a3dacb0b54aac9265dbee34f23249
55 Nc0b946c2a84149d88dfb6906d4fa18c1
56 sg:journal.1094205
57 schema:name Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★
58 schema:pagination 295-302
59 schema:productId N5425f33863ac4ac1b8e1e242d35bcc7c
60 Nb25ad8217453428fbef84d982cac5804
61 Nb3abdea625d240a8b9d992e07c19d7d2
62 Ncc7fedeac4b44366bc8364efb9456f62
63 Ne6c16fc69ccb40ae87911d2be434384d
64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049009949
65 https://doi.org/10.1007/s11060-005-9098-5
66 schema:sdDatePublished 2019-04-10T19:13
67 schema:sdLicense https://scigraph.springernature.com/explorer/license/
68 schema:sdPublisher Ne8fb801f5741471585303976c15116e4
69 schema:url http://link.springer.com/10.1007%2Fs11060-005-9098-5
70 sgo:license sg:explorer/license/
71 sgo:sdDataset articles
72 rdf:type schema:ScholarlyArticle
73 N0d353eb3e3c8401bb498f2fc8b1f95df rdf:first sg:person.0723474462.08
74 rdf:rest Nb6a33050d1fa4886aeb3541ff9c2fcd2
75 N16f8434d96aa4485aa6cf0688ed25622 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 N1f15e54bb85b4211be2de032aa04933d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Male
80 rdf:type schema:DefinedTerm
81 N2063ac7adbb14f5aa1056fde400c5b86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Aged
83 rdf:type schema:DefinedTerm
84 N250d3118ab814c8f81e8d05dd5adf6b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Matrix Metalloproteinases
86 rdf:type schema:DefinedTerm
87 N290a3dacb0b54aac9265dbee34f23249 schema:volumeNumber 78
88 rdf:type schema:PublicationVolume
89 N2ab583f22a2e485fa136000eaaadd2ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Brain Neoplasms
91 rdf:type schema:DefinedTerm
92 N38fb29308de644d88b573e99017a674d schema:name The Marimastat Glioblastoma Study Group* and British Biotech, Oxford, UK
93 rdf:type schema:Organization
94 N429ae8657a5e4d44b184f46453cc217b rdf:first sg:person.0751336044.35
95 rdf:rest Nd7878eb656cd4317a605b23d8be923b0
96 N479c3105b31e4e4b9a97d7c90419c386 schema:affiliation N38fb29308de644d88b573e99017a674d
97 schema:familyName Baillet
98 schema:givenName Mark
99 rdf:type schema:Person
100 N52a0a134f6c04097b08ac83367fc8ee8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Glioblastoma
102 rdf:type schema:DefinedTerm
103 N53a89e8888b1451c9adb8d63d029677c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Hydroxamic Acids
105 rdf:type schema:DefinedTerm
106 N5425f33863ac4ac1b8e1e242d35bcc7c schema:name dimensions_id
107 schema:value pub.1049009949
108 rdf:type schema:PropertyValue
109 N5c0469a79e4b43cf8d12b512d4cdd339 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Matrix Metalloproteinase Inhibitors
111 rdf:type schema:DefinedTerm
112 N5fba498171c64bd9999ec95905cdd531 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Adult
114 rdf:type schema:DefinedTerm
115 N6f0524d307d54a01b6d7beaa37c1e54d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Musculoskeletal Diseases
117 rdf:type schema:DefinedTerm
118 N7e2a5327350e4082a366d322bfd38360 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Gliosarcoma
120 rdf:type schema:DefinedTerm
121 N909e77b257dd44d2a5e105633da1a49e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Treatment Failure
123 rdf:type schema:DefinedTerm
124 N975e7d0be2f542858e3187737baeacf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Combined Modality Therapy
126 rdf:type schema:DefinedTerm
127 Na13ab9ddac824dfd86bbf93256d55eda rdf:first sg:person.01346246457.67
128 rdf:rest Nb127c318cf914ae5af47342b1575ab2e
129 Na644075a55334a898b2e92af53d37626 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Survival Analysis
131 rdf:type schema:DefinedTerm
132 Nb127c318cf914ae5af47342b1575ab2e rdf:first sg:person.016341673457.32
133 rdf:rest N0d353eb3e3c8401bb498f2fc8b1f95df
134 Nb25ad8217453428fbef84d982cac5804 schema:name pubmed_id
135 schema:value 16636750
136 rdf:type schema:PropertyValue
137 Nb2d738adbf9042ccb511b81ce48ce777 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Quality of Life
139 rdf:type schema:DefinedTerm
140 Nb3abdea625d240a8b9d992e07c19d7d2 schema:name nlm_unique_id
141 schema:value 8309335
142 rdf:type schema:PropertyValue
143 Nb6a33050d1fa4886aeb3541ff9c2fcd2 rdf:first sg:person.0636405632.56
144 rdf:rest N429ae8657a5e4d44b184f46453cc217b
145 Nbcbe7ccc85d74cfa8cbde7b32c555826 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Middle Aged
147 rdf:type schema:DefinedTerm
148 Nc0b946c2a84149d88dfb6906d4fa18c1 schema:issueNumber 3
149 rdf:type schema:PublicationIssue
150 Ncc7fedeac4b44366bc8364efb9456f62 schema:name readcube_id
151 schema:value e979d36a22b7f32ec25a18a3d21d3da8291e74bcd87f06b2630c209a42bf00cd
152 rdf:type schema:PropertyValue
153 Ncfef4207b1394278bcda848e3fb48bb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Double-Blind Method
155 rdf:type schema:DefinedTerm
156 Nd7878eb656cd4317a605b23d8be923b0 rdf:first sg:person.013732343337.08
157 rdf:rest Ne0db491d29a54708bc8aba4eafdcbf0a
158 Ne0db491d29a54708bc8aba4eafdcbf0a rdf:first N479c3105b31e4e4b9a97d7c90419c386
159 rdf:rest rdf:nil
160 Ne6c16fc69ccb40ae87911d2be434384d schema:name doi
161 schema:value 10.1007/s11060-005-9098-5
162 rdf:type schema:PropertyValue
163 Ne8fb801f5741471585303976c15116e4 schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Ne9752604f40b4c7a86671a06255aac6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Enzyme Inhibitors
167 rdf:type schema:DefinedTerm
168 Nf19eb3c110ec499d98afdb1e565a126f rdf:first sg:person.0750205222.87
169 rdf:rest Na13ab9ddac824dfd86bbf93256d55eda
170 Nfc5c687d77514803983e90a174a00c29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Female
172 rdf:type schema:DefinedTerm
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
177 schema:name Oncology and Carcinogenesis
178 rdf:type schema:DefinedTerm
179 sg:journal.1094205 schema:issn 0167-594X
180 1573-7373
181 schema:name Journal of Neuro-Oncology
182 rdf:type schema:Periodical
183 sg:person.01346246457.67 schema:affiliation https://www.grid.ac/institutes/grid.189967.8
184 schema:familyName Phuphanich
185 schema:givenName Surasak
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346246457.67
187 rdf:type schema:Person
188 sg:person.013732343337.08 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
189 schema:familyName Fuller
190 schema:givenName Gregory N.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013732343337.08
192 rdf:type schema:Person
193 sg:person.016341673457.32 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
194 schema:familyName Alfred Yung
195 schema:givenName W.K.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016341673457.32
197 rdf:type schema:Person
198 sg:person.0636405632.56 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
199 schema:familyName Del Maestro
200 schema:givenName Rolando
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636405632.56
202 rdf:type schema:Person
203 sg:person.0723474462.08 schema:affiliation https://www.grid.ac/institutes/grid.413574.0
204 schema:familyName Forsyth
205 schema:givenName Peter A.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723474462.08
207 rdf:type schema:Person
208 sg:person.0750205222.87 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
209 schema:familyName Levin
210 schema:givenName Victor A.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750205222.87
212 rdf:type schema:Person
213 sg:person.0751336044.35 schema:affiliation https://www.grid.ac/institutes/grid.413104.3
214 schema:familyName Perry
215 schema:givenName James R.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751336044.35
217 rdf:type schema:Person
218 sg:pub.10.1007/bf00157681 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026844027
219 https://doi.org/10.1007/bf00157681
220 rdf:type schema:CreativeWork
221 sg:pub.10.1007/bf00157684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008182837
222 https://doi.org/10.1007/bf00157684
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/nrc1121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015454211
225 https://doi.org/10.1038/nrc1121
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/nrc884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004342262
228 https://doi.org/10.1038/nrc884
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/sj.onc.1204097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050913107
231 https://doi.org/10.1038/sj.onc.1204097
232 rdf:type schema:CreativeWork
233 sg:pub.10.1054/bjoc.2000.1316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045826895
234 https://doi.org/10.1054/bjoc.2000.1316
235 rdf:type schema:CreativeWork
236 https://app.dimensions.ai/details/publication/pub.1074718587 schema:CreativeWork
237 https://app.dimensions.ai/details/publication/pub.1075265107 schema:CreativeWork
238 https://app.dimensions.ai/details/publication/pub.1082676509 schema:CreativeWork
239 https://app.dimensions.ai/details/publication/pub.1083269733 schema:CreativeWork
240 https://doi.org/10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007980454
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1002/1097-0142(19950301)75:5<1151::aid-cncr2820750515>3.0.co;2-q schema:sameAs https://app.dimensions.ai/details/publication/pub.1006358852
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1002/cpt1974155443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048844100
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/0065-2571(94)00022-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1052218121
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1074/jbc.272.46.28823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039952409
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1074/jbc.274.33.23349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039215449
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1074/jbc.274.41.29568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044358587
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1074/jbc.m006871200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000021777
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1093/oxfordjournals.annonc.a059091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082936497
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1126/science.1067100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062445674
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1200/jco.1990.8.7.1277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716995
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1200/jco.20.5.1383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202863
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1200/jco.2000.18.7.1481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074611338
265 rdf:type schema:CreativeWork
266 https://doi.org/10.3171/jns.1977.47.3.0329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071091255
267 rdf:type schema:CreativeWork
268 https://doi.org/10.3171/jns.1996.84.1.0029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071097867
269 rdf:type schema:CreativeWork
270 https://www.grid.ac/institutes/grid.189967.8 schema:alternateName Emory University
271 schema:name Department of Hematology-Oncology, Winship Cancer Institute, Emory University, 30322, Atlanta, GA, USA
272 rdf:type schema:Organization
273 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
274 schema:name Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA
275 Department of Pathology, The University of Texas M. D. Anderson Cancer Center, 77030, Houston, TX, USA
276 Neuro-Oncology Unit 431, UT M. D. Anderson Cancer Center, P.O. Box 301402, 77230-1402, Houston, TX, USA
277 rdf:type schema:Organization
278 https://www.grid.ac/institutes/grid.39381.30 schema:alternateName Western University
279 schema:name Department of Neurosciences, Division of Neurosurgery, University of Western Ontario, London, Ontario, Canada
280 rdf:type schema:Organization
281 https://www.grid.ac/institutes/grid.413104.3 schema:alternateName Sunnybrook Health Science Centre
282 schema:name Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
283 rdf:type schema:Organization
284 https://www.grid.ac/institutes/grid.413574.0 schema:alternateName Alberta Health Services
285 schema:name Tom Baker Cancer Center, Calgary, Alberta, Canada
286 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...